Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 2582179, 5 pages
https://doi.org/10.1155/2018/2582179
Research Article

BRAF 1799T>A Mutation Frequency in Mexican Mestizo Patients with Papillary Thyroid Cancer

1Unidad de Genética, Hospital General de México, Dr. Balmis 148, Cuauhtémoc, 06720 México City, Mexico
2Servicio de Cirugía, Hospital General de México, Dr. Balmis 148, Cuauhtémoc, 06720 México City, Mexico
3Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Av. Instituto Politécnico Nacional 2508, San Pedro Zacatenco, 07360 México City, Mexico
4Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina-IPN, Plan de San Luis y Díaz Mirón s/n, Miguel Hidalgo, 11340 México City, Mexico
5Catedrático CONACyT, Unidad de Investigación Médica en Epidemiología Clínica, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Cuauhtémoc, 06270 México City, Mexico

Correspondence should be addressed to Fernando Fernández-Ramírez; xm.manu.saicneic@zednanreff

Received 1 December 2017; Revised 19 February 2018; Accepted 22 February 2018; Published 2 April 2018

Academic Editor: Salvatore Gallone

Copyright © 2018 Fernando Fernández-Ramírez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Hurtado-López, E. Basurto-Kuba, E. R. Montes de Oca-Durán ER et al., “Prevalencia de nódulo tiroideo en el valle de México,” Cirugía y Cirujanos, vol. 79, no. 2, pp. 114–117, 2011. View at Google Scholar
  2. E. J. Lee, K. H. Song, D. L. Kim, Y. M. Jang, T. S. Hwang, and S. K. Kim, “The BRAF V600E mutation is associated with malignant ultrasonographic features in thyroid nodules,” Clinical Endocrinology, vol. 75, no. 6, pp. 844–850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Miller, S. Burkey, G. Lindberg, W. H. Snyder III, and F. E. Nwariaku, “Prevalence of malignancy within cytologically indeterminate thyroid nodules,” The American Journal of Surgery, vol. 188, no. 5, pp. 459–462, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Moses, J. Weng, I. Sansano et al., “Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy,” World Journal of Surgery, vol. 34, no. 11, pp. 2589–2594, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Rossi, M. Buratto, F. Tagliati et al., “Relevance of BRAFV600E mutation testing versus RAS point mutations and RET/PTC rearrangements. Evaluation in the diagnosis of thyroid cancer,” Thyroid, vol. 25, no. 2, pp. 221–228, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Li, G. Chen, C. Sheng et al., “BRAFV600E mutation in papillary thyroid microcarcinoma: A meta-analysis,” Endocrine-Related Cancer, vol. 22, no. 2, pp. 159–168, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Kleiman, M. J. Sporn, T. Beninato et al., “Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients,” Cancer, vol. 119, no. 8, pp. 1495–1502, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. E. Nikiforov, S. E. Carty, S. I. Chiosea et al., “Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology,” Thyroid, vol. 25, no. 11, pp. 1217–1223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. E. S. Cibas and S. Z. Ali, “The 2017 Bethesda System for Reporting Thyroid Cytopathology,” Thyroid, vol. 27, no. 11, pp. 1341–1346, 2017. View at Publisher · View at Google Scholar
  10. G. Gandolfi, V. Sancisi, S. Piana, and A. Ciarrocchi, “Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma,” International Journal of Cancer, vol. 137, no. 5, pp. 1001–1011, 2015. View at Publisher · View at Google Scholar
  11. D. G. Altman and J. M. Bland, “Diagnostic tests 1: sensitivity and specificity,” British Medical Journal, vol. 308, no. 6943, p. 1552, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. D. G. Altman and J. M. Bland, “Diagnostic tests 2: predictive values,” British Medical Journal, vol. 309, no. 6947, p. 102, 1994. View at Google Scholar · View at Scopus
  13. E. Horvath, S. Majlis, R. Rossi et al., “An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 5, pp. 1748–1751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Bray, J. S. Ren, E. Masuyer, and J. Ferlay, “Global estimates of cancer prevalence for 27 sites in the adult population in 2008,” International Journal of Cancer, vol. 132, no. 5, pp. 1133–1145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. B. R. Haugen, E. K. Alexander, and K. C. Bible, “American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 26, no. 1, pp. 1–133, 2015. View at Publisher · View at Google Scholar
  16. L. Hegedüs, “The thyroid nodule,” The New England Journal of Medicine, vol. 351, no. 17, pp. 1764–1809, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. J. Mandel, “Diagnostic use of ultrasonography in patients with nodular thyroid disease,” Endocrine Practice, vol. 10, no. 3, pp. 246–252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Xing, D. Clark, H. Guan et al., “BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer,” Journal of Clinical Oncology, vol. 27, no. 18, pp. 2977–2982, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. E. Nikiforov, D. L. Steward, T. M. Robinson-Smith et al., “Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules,” The Journal of Clinical Endocrinology Metabolism, vol. 94, no. 6, pp. 2092–2098, 2009. View at Google Scholar
  20. S. Y. Nam, B. K. Han, E. Y. Ko et al., “BRAFV600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: A potential guide for selection of samples for molecular analysis,” Thyroid, vol. 20, no. 3, pp. 273–279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. N. A. Samaan, P. N. Schulz, R. C. Hickey et al., “The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patient,” The Journal of Clinical Endocrinology & Metabolism, vol. 75, no. 3, pp. 714–720, 1992. View at Google Scholar
  22. C. Durante, T. Montesano, M. Torlontano et al., “Papillary thyroid cancer: time course of recurrences during 226 postsurgery surveillance,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 2, pp. 636–642, 2013. View at Google Scholar
  23. M. Xing, “BRAFV600E mutation and papillary thyroid cancer: Chicken or egg?” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 7, pp. 2295–2298, 2012. View at Publisher · View at Google Scholar · View at Scopus